Atlas Trials

UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

Clinical trial NCT05848999 · UNKNOWN

Trial details

NCT number
NCT05848999
Sponsor
Zhejiang University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Mesothelin-positive Advanced Malignant Solid Tumors
Start date
2023-04-27
Primary completion
2025-05-01
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.